BRIEF-Pfizer says its biosimilar wins Norwegian infliximab biosimilar tender

* Says Norwegian Drug Procurement Cooperation (LIS) awards infliximab biosimilar tender to its product Inflectra Further company coverage: (Reporting by UK bureau)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.